ResMed Statement on DPA
April 02 2020 - 9:58PM
Business Wire
ResMed (NYSE: RMD, ASX: RMD) has released the following
statement regarding today’s White House Memorandum on Order Under
the Defense Production Act Regarding the Purchase of
Ventilators:
“ResMed is pleased to see the White House prioritize access to
critical ventilator components, enabling not only ResMed but all
industry-leading ventilator manufacturers to speed up both
production and delivery of lifesaving devices to patients who need
them most.
“We encourage automakers, aerospace equipment producers, and
other non-ventilation manufacturers to help us source or create
more of these components and accessories for ventilators,
strengthening the supply chain that all ventilator makers are
drawing from to help meet this rising global demand and save
lives.”
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our cloud-connected medical
devices transform care for people with sleep apnea, COPD, and other
chronic diseases. Our comprehensive out-of-hospital software
platforms support the professionals and caregivers who help people
stay healthy in the home or care setting of their choice. By
enabling better care, we improve quality of life, reduce the impact
of chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit ResMed.com
and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200402005886/en/
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Apr 2023 to Apr 2024